# Serum Endostatin Type 2 Diabetic Patients

> **NCT03404037** · — · COMPLETED · sponsor: **Zagazig University** · enrollment: 110 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Coronary Artery Disease
- Coronary Arteriosclerosis

## Interventions

- **DIAGNOSTIC_TEST:** serum endostatin level

## Key facts

- **NCT ID:** NCT03404037
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-02
- **Primary completion:** 2017-11-11
- **Final completion:** 2017-12-20
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2018-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03404037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03404037, "Serum Endostatin Type 2 Diabetic Patients". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03404037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*